Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Exocrine Pancreatic Insufficiency Market By 2029?
The exocrine pancreatic insufficiency market has seen substantial expansion in recent years. Its valuation is anticipated to rise from $2.59 billion in 2024 to $2.75 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.4%. This historical progression is due to factors such as enhanced awareness and detection, the increasing occurrence of digestive disorders, an aging demographic and subsequent reduction in pancreatic function, and a rise in gastrointestinal surgical procedures.
The exocrine pancreatic insufficiency market size is projected to experience robust growth in the coming years. This market is expected to expand to $3.59 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.9%. The projected growth is attributable to an ongoing rise in awareness and screening, an expanding geriatric population, an increasing occurrence of chronic diseases, improved patient access to healthcare, and advancements in digestive health research and development. Significant trends for the forecast period include the adoption of telehealth and digital health solutions, collaborative research efforts, a focus on pediatric exocrine pancreatic insufficiency, advancements in regulatory processes and fast-track designations, market expansion into emerging economies, and improvements in healthcare infrastructure.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp
Which Major Market Drivers Are Shaping The Future Of The Exocrine Pancreatic Insufficiency Market?
The increasing prevalence of chronic diseases is anticipated to fuel the expansion of the exocrine pancreatic insufficiency market. Chronic diseases, defined as long-term medical conditions persisting for typically three months or more, often lead to secondary complications such as exocrine pancreatic insufficiency due to their prolonged presence. This situation drives the advancement of medical interventions and therapies for better management of chronic conditions, potentially leading to longer life spans for affected individuals. Supporting this trend, the World Health Organization noted in September 2023 that 41 million deaths occur annually, with 74% attributed globally to non-communicable diseases (NCDs) or chronic diseases. Consequently, the rising incidence of chronic diseases is set to propel the growth of the exocrine pancreatic insufficiency market.
What Are The Segment Types Shaping The Exocrine Pancreatic Insufficiency Market?
The exocrine pancreatic insufficiencymarket covered in this report is segmented –
1) By Treatment: Nutritional Management; Pancreatic Enzyme Replacement Therapy (PERT); Other Treatments
2) By Diagnosis: Imaging Tests; Computed Tomography (CT) Scan; Abdominal Ultrasound; Secretin Pancreatic Function Test; Fecal Fat Test; Fecal Elastase Test (FE-1); Other Types
3) By Symptoms: Abdominal Pain; Constipation; Diarrhea; Fatty Stools; Weight Loss; Other Symptoms
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End Users: Hospitals; Specialty Clinics; Homecare
Subsegments:
1) By Nutritional Management: Dietary Modifications; Nutritional Supplements
2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules; Non-Enteric-Coated Capsules; Powder Formulations
3) By Other Treatments: Medications; Surgical Interventions; Supportive Therapies
Which Key Trends Are Expected To Influence The Exocrine Pancreatic Insufficiency Market In The Coming Years?
Leading companies in the exocrine pancreatic insufficiency market are concentrating on forming patient advocacy groups, including initiatives focused on comprehensive nutritional guidance, to offer extensive nutritional advice and assistance. These efforts are designed to heighten awareness, improve education, and enhance the management of the condition among affected individuals. Comprehensive nutritional guidance adopts a holistic method, adjusting dietary recommendations to suit individual requirements, health circumstances, and lifestyles. It places importance on education, meal preparation, and sustainable habits to advance overall well-being. For example, in June 2024, Nestlé Health Science, a Switzerland-based nutrition company, unveiled a GLP-1 nutrition support platform. Nestlé Health Science’s GLP-1 nutrition support platform delivers personalized nutritional resources and expert direction for individuals utilizing GLP-1 medications, prioritizing muscle maintenance, digestive health, and complete wellness. Its aim is to empower users on their weight management path by addressing distinct dietary needs and encouraging community backing.
Which Industry Leaders Are Driving Innovation Across The Exocrine Pancreatic Insufficiency Market?
Major companies operating in the exocrine pancreatic insufficiency market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Nestle Health Science S.A., Allergan PLC, Chiesi Farmaceutici S.p.A., Wockhardt Ltd., Amryt Pharma PLC, Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, Aimmune Therapeutics Inc., Digestive Care Inc., Enzymedica Inc., Vivus Inc., Alcresta Therapeutics Inc., Cilian AG, Perseo Pharma AG, Enzyme Development Corporation, First Wave BioPharma Inc., Synspira Therapeutics
Download The Full Report For Exclusive Market Findings:
How Does The Exocrine Pancreatic Insufficiency Market Perform Across Key Geographic Regions?
North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Exocrine Pancreatic Insufficiency Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13107&type=smp
Browse Through More Reports Similar to the Global Exocrine Pancreatic Insufficiency Market 2025, By The Business Research Company
Exocrine Pancreatic Insufficiency Epi Therapeutics And Diagnostics Global Market Report 2025
Mineral And Bone Disorder Treatment Global Market Report 2025
Home Infusion Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model